Famotidine

Product NDC: 50090-3888
Requested package NDC: 50090-3888-0
11-digit product format: 500903888
Labeler code: 50090
Product ID: 50090-3888_d05f1236-0e04-48cc-847e-a2ed82005481
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Famotidine
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA206530
Marketing category: ANDA
Marketing start: 2015-12-22
Marketing end: 0000-00-00
Substance: FAMOTIDINE
Active strength: 40 mg/1
Pharmacologic classes: Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	50090-3888	50090-3888-0	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 2 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-3888	50090-3888-0	D	Discontinued by firm		excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-3888	50090-3888-0	D	Discontinued by firm		excluded / ndc_excluded.zip	`f5e01cc5f278…`	`a2eaf40c39c3…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A206530-001	FAMOTIDINE	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22
A206530-002	FAMOTIDINE	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A206530-001	AB
A206530-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB		2015-12-22	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A206530-001	FAMOTIDINE	20MG	TABLET / ORAL	AB		2015-12-22	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A206530-002	FAMOTIDINE	40MG	TABLET / ORAL	AB	RS	2015-12-22	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A206530-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206530-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206530-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206530-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206530-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206530-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206530-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206530-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206530-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206530-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206530-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206530-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206530-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206530-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206530-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206530-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206530-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206530-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206530-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206530-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206530-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206530-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206530-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206530-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206530-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206530-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206530-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A206530-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206530-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206530-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206530-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A206530-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206530-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A206530-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206530-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A206530-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206530-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A206530-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A206530-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A206530-002	AB	1	`782e0a99824c…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
50090-3888-0	2023-02-07	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
50090-3888-1	2023-02-07	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
50090-3888-0	2023-01-30	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986
50090-3888-1	2023-01-30	These highlights do not include all the information needed to use FAMOTIDINE TABLETS safely and effectively. See full prescribing information for FAMOTIDINE TABLETS. FAMOTIDINE tablets, for oral use Initial U.S. Approval: 1986

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-3888-0	EA - Each	50090-3888	40d82fea-6bd1-4fd9-93d1-323643f59405	1	2021-12-08
50090-3888-1	EA - Each	50090-3888	ab001005-115d-4495-9239-7e7e550ef694	1	2021-12-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-3888	FAMOTIDINE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS]	9	Legacy NDC	20231219_e9102fd9-ca26-4a2c-9b1a-6e75a208fc11.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Famotidine	FAMOTIDINE	Unit Dose Solutions, Inc.	54d93bf1-8f9a-981b-e063-6394a90a0fde	2026-06-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	Bryant Ranch Prepack	11ce2a78-76ce-44df-afe3-57493498e596	2025-04-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	Aurobindo Pharma Limited	b0798337-1a73-415e-8416-613984ce5c65	2025-03-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	American Health Packaging	3a583080-6771-4246-a221-2491e9e5d8af	2024-09-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	Proficient Rx LP	4adb4864-04ac-4cb1-96c2-6196a30ac640	2024-09-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	A-S Medication Solutions	d8cfa644-7cad-41b9-82a0-242a783fcbc8	2023-12-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	Proficient Rx LP	f32d0929-de22-4bec-9e24-bb549cf2679f	2022-09-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530
Famotidine	FAMOTIDINE	BluePoint Laboratories	8c7ca3cc-ff90-42a7-9218-554cf15348a3	2021-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206530 application number: ANDA206530

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5QZO15J2Z8	FAMOTIDINE	76824-35-6	FAMOTIDINE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-3888-0	50090388800	30 TABLET, FILM COATED in 1 BOTTLE (50090-3888-0)	2018-11-30	0000-00-00	No	No	Current